ATE129896T1 - Anthracyclin-glucosid enthaltende einspritzbare gebrauchsfertige lösungen gegen krebs. - Google Patents

Anthracyclin-glucosid enthaltende einspritzbare gebrauchsfertige lösungen gegen krebs.

Info

Publication number
ATE129896T1
ATE129896T1 AT91102986T AT91102986T ATE129896T1 AT E129896 T1 ATE129896 T1 AT E129896T1 AT 91102986 T AT91102986 T AT 91102986T AT 91102986 T AT91102986 T AT 91102986T AT E129896 T1 ATE129896 T1 AT E129896T1
Authority
AT
Austria
Prior art keywords
ready
injectable solutions
against cancer
cancer containing
solutions against
Prior art date
Application number
AT91102986T
Other languages
English (en)
Inventor
Gaetano Gatti
Diego Oldani
Giuseppe Bottoni
Carlo Confalonieri
Luciano Gambini
Ponti Roberto De
Original Assignee
Pharmacia Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26291656&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE129896(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from GB868629193A external-priority patent/GB8629193D0/en
Application filed by Pharmacia Spa filed Critical Pharmacia Spa
Application granted granted Critical
Publication of ATE129896T1 publication Critical patent/ATE129896T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
    • A61K31/704—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin attached to a condensed carbocyclic ring system, e.g. sennosides, thiocolchicosides, escin, daunorubicin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Dermatology (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Saccharide Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT91102986T 1986-12-05 1987-12-03 Anthracyclin-glucosid enthaltende einspritzbare gebrauchsfertige lösungen gegen krebs. ATE129896T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB868629193A GB8629193D0 (en) 1986-12-05 1986-12-05 Injectable ready-to-use solutions
US6465387A 1987-06-22 1987-06-22

Publications (1)

Publication Number Publication Date
ATE129896T1 true ATE129896T1 (de) 1995-11-15

Family

ID=26291656

Family Applications (2)

Application Number Title Priority Date Filing Date
AT95101919T ATE240108T1 (de) 1986-12-05 1987-12-03 Doxorubicin enthaltende einspritzbare gebrauchsfertige lösungen gegen krebs
AT91102986T ATE129896T1 (de) 1986-12-05 1987-12-03 Anthracyclin-glucosid enthaltende einspritzbare gebrauchsfertige lösungen gegen krebs.

Family Applications Before (1)

Application Number Title Priority Date Filing Date
AT95101919T ATE240108T1 (de) 1986-12-05 1987-12-03 Doxorubicin enthaltende einspritzbare gebrauchsfertige lösungen gegen krebs

Country Status (22)

Country Link
EP (4) EP0438183B1 (de)
JP (1) JP2621255B2 (de)
KR (2) KR960007861B1 (de)
CN (1) CN1058391C (de)
AT (2) ATE240108T1 (de)
AU (1) AU632036B2 (de)
BE (1) BE1000540A5 (de)
CH (1) CH680494A5 (de)
DE (4) DE3741037A1 (de)
DK (1) DK175815B1 (de)
ES (3) ES2039460T3 (de)
FI (1) FI91710C (de)
FR (1) FR2607702B1 (de)
GB (1) GB2200047B (de)
GR (2) GR871846B (de)
HK (3) HK39591A (de)
IT (1) IT1226072B (de)
NL (1) NL8702914A (de)
NO (1) NO175802C (de)
PT (1) PT86285B (de)
SE (1) SE512881C2 (de)
SG (1) SG36591G (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8519452D0 (en) * 1985-08-02 1985-09-11 Erba Farmitalia Injectable solutions
DE10300323A1 (de) * 2003-01-09 2004-10-14 Baxter Healthcare S.A. Sicherheitsbehälter mit erhöhter Bruch und Splitterfestigkeit sowie kontaminationsfreier Außenfläche für biologisch aktive Substanzen und Verfahren zu deren Herstellung
CA2446837C (en) * 2001-05-11 2012-01-03 Mitsubishi Pharma Corporation Stable high-concentration injection containing pyrazolone derivative
AU2006213440A1 (en) * 2005-02-11 2006-08-17 Dabur Pharma Limited Stabilized anthracycline glycoside pharmaceutical compositions
EP1814525A2 (de) * 2005-05-11 2007-08-08 Sicor Inc. Stabile lyophilisierte anthracyclin-glycoside
MX2010001263A (es) * 2007-09-04 2010-10-04 Meiji Seika Kaisha Inyeccion, solucion de inyeccion y preparacion de equipo de inyeccion.
EP2174651A1 (de) * 2008-10-09 2010-04-14 Charité-Universitätsmedizin Berlin (Charité) Polymerfreies Hydrogel
CN102614118B (zh) * 2012-03-15 2014-04-30 北京协和药厂 注射用盐酸表柔比星制剂的制备方法及制剂
CN111617030B (zh) * 2020-05-22 2021-09-07 广东药科大学 壳寡糖口服液及其在制备减肥药物中的应用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4177264A (en) * 1977-10-17 1979-12-04 Sri International N-benzyl anthracyclines
GB2007645B (en) * 1977-10-17 1982-05-12 Stanford Res Inst Int Benzyl anthracyclines and pharmaceutical compositions containing them
GB2187311B (en) * 1984-07-27 1988-02-10 Ae Plc Automatic vehicle speed control system
GB8426672D0 (en) * 1984-10-22 1984-11-28 Erba Farmitalia Pharmaceutical compositions
GB8519452D0 (en) * 1985-08-02 1985-09-11 Erba Farmitalia Injectable solutions
JPH0655667A (ja) * 1992-08-06 1994-03-01 Nippon Zeon Co Ltd 複合成形体

Also Published As

Publication number Publication date
SG36591G (en) 1991-06-21
FR2607702A1 (fr) 1988-06-10
EP0438183B1 (de) 1995-11-08
DE3752368D1 (de) 2003-06-18
ES2039460T3 (es) 1993-10-01
ES2198424T3 (es) 2004-02-01
ES2082023T3 (es) 1996-03-16
ATE240108T1 (de) 2003-05-15
CN1058391C (zh) 2000-11-15
NL8702914A (nl) 1988-07-01
DE3751589D1 (de) 1995-12-14
DE3777365D1 (de) 1992-04-16
KR880007086A (ko) 1988-08-26
DE3741037A1 (de) 1988-06-09
KR0158672B1 (en) 1998-12-01
IT8722869A0 (it) 1987-12-03
HK1049440A1 (zh) 2003-05-16
EP0438183A1 (de) 1991-07-24
PT86285A (en) 1988-01-01
NO875055L (no) 1988-06-06
FI875340A0 (fi) 1987-12-03
AU8205987A (en) 1988-06-09
EP1283044A3 (de) 2003-05-14
GR871846B (en) 1988-04-01
JP2621255B2 (ja) 1997-06-18
SE512881C2 (sv) 2000-05-29
DE3751589T2 (de) 1996-05-02
HK39591A (en) 1991-05-31
GR3004303T3 (de) 1993-03-31
EP0273603A2 (de) 1988-07-06
FI91710C (fi) 1994-08-10
JPS63215633A (ja) 1988-09-08
NO875055D0 (no) 1987-12-03
GB8728313D0 (en) 1988-01-06
EP0273603A3 (en) 1988-07-20
NO175802C (no) 1994-12-14
KR960007861B1 (ko) 1996-06-13
BE1000540A5 (fr) 1989-01-24
DK635287A (da) 1988-06-06
AU632036B2 (en) 1992-12-17
HK1011288A1 (en) 1999-07-09
DK635287D0 (da) 1987-12-03
EP0659435B1 (de) 2003-05-14
PT86285B (pt) 1990-11-07
NO175802B (no) 1994-09-05
IT1226072B (it) 1990-12-10
GB2200047B (en) 1990-11-21
CN87108225A (zh) 1988-09-14
FR2607702B1 (fr) 1991-08-16
EP0659435A1 (de) 1995-06-28
FI91710B (fi) 1994-04-29
FI875340A (fi) 1988-06-06
SE8704849L (sv) 1988-06-06
GB2200047A (en) 1988-07-27
EP0273603B1 (de) 1992-03-11
CH680494A5 (de) 1992-09-15
SE8704849D0 (sv) 1987-12-03
DK175815B1 (da) 2005-03-07
EP1283044A2 (de) 2003-02-12
DE3752368T2 (de) 2004-02-12

Similar Documents

Publication Publication Date Title
ATE74522T1 (de) Lyophilisierte pharmazeutische zubereitung eines neocarzinostatinderivates.
FI875533A0 (fi) Insulinpreparat foer non-parenteral dosering.
SE8602743D0 (sv) Injectable ready-to-use solutions containing an antitumor anthracycline glycoside
DE68906045T2 (de) 3'-deamino-4'-deoxy-4'-aminoanthracycline.
ATE129896T1 (de) Anthracyclin-glucosid enthaltende einspritzbare gebrauchsfertige lösungen gegen krebs.
DK640587A (da) Cytostatisk virksomme anthracyclinderivater cytostatisk virksomme anthracyclinderivater
DE3873011D1 (de) Pharmazeutische zusammensetzung, enthaltend piperidinalkanolderivate.
DE3866747D1 (de) Jod enthaltende pharmazeutische zubereitung.
MY104837A (en) Injectable ready-to-use solutions containing an antitumor anthracycline glycoside

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
EEIH Change in the person of patent owner
EELA Cancelled due to lapse of time